A significant advance in cancer research is emerging with the use of mini-antibodies to restore mutated p53. This essential tumor inhibitor protein is frequently inactivated in various kinds of malignancies, resulting https://bookmarkstown.com/story22202625/nanobodies-reactivate-p53-a-new-approach-for-tumor-management